Xuefei Jia

910 total citations
41 papers, 589 citations indexed

About

Xuefei Jia is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Xuefei Jia has authored 41 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 14 papers in Genetics. Recurrent topics in Xuefei Jia's work include Brain Metastases and Treatment (14 papers), Glioma Diagnosis and Treatment (10 papers) and Lung Cancer Research Studies (6 papers). Xuefei Jia is often cited by papers focused on Brain Metastases and Treatment (14 papers), Glioma Diagnosis and Treatment (10 papers) and Lung Cancer Research Studies (6 papers). Xuefei Jia collaborates with scholars based in United States and China. Xuefei Jia's co-authors include Gene H. Barnett, Samuel T. Chao, John H. Suh, Michael A. Vogelbaum, Manmeet S. Ahluwalia, Alok A. Khorana, Erin S. Murphy, Jennifer S. Yu, Lorenzo Gervaso and Alireza M. Mohammadi and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of neurosurgery.

In The Last Decade

Xuefei Jia

35 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xuefei Jia United States 14 256 251 194 92 79 41 589
Giovanni Scarzello Italy 17 386 1.5× 202 0.8× 135 0.7× 93 1.0× 32 0.4× 52 690
Angela Giardino United States 17 340 1.3× 82 0.3× 222 1.1× 84 0.9× 53 0.7× 34 873
D. Zierhut Germany 16 336 1.3× 123 0.5× 195 1.0× 84 0.9× 50 0.6× 32 823
Massimo Castellani Italy 18 266 1.0× 74 0.3× 141 0.7× 105 1.1× 82 1.0× 77 843
Archi Agrawal India 15 341 1.3× 85 0.3× 237 1.2× 85 0.9× 66 0.8× 165 913
Cinzia Iotti Italy 20 487 1.9× 100 0.4× 182 0.9× 85 0.9× 95 1.2× 80 953
S Bárrena Spain 15 101 0.4× 120 0.5× 112 0.6× 34 0.4× 33 0.4× 48 737
Salvina Barra Italy 17 283 1.1× 144 0.6× 90 0.5× 65 0.7× 41 0.5× 61 683
Richard J. Cassidy United States 19 502 2.0× 115 0.5× 405 2.1× 128 1.4× 138 1.7× 50 934
Wynnie W.M. Lam Hong Kong 13 194 0.8× 71 0.3× 188 1.0× 131 1.4× 47 0.6× 19 730

Countries citing papers authored by Xuefei Jia

Since Specialization
Citations

This map shows the geographic impact of Xuefei Jia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefei Jia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefei Jia more than expected).

Fields of papers citing papers by Xuefei Jia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuefei Jia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefei Jia. The network helps show where Xuefei Jia may publish in the future.

Co-authorship network of co-authors of Xuefei Jia

This figure shows the co-authorship network connecting the top 25 collaborators of Xuefei Jia. A scholar is included among the top collaborators of Xuefei Jia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefei Jia. Xuefei Jia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Dima, Danai, Fauzia Ullah, Xuefei Jia, et al.. (2024). Real‐world outcomes of patients with resected stage III melanoma treated with adjuvant therapies. Cancer Medicine. 13(12). e7257–e7257. 2 indexed citations
5.
Davis, James A., Danai Dima, Nausheen Ahmed, et al.. (2023). Impact of Frailty on Outcomes after Chimeric Antigen Receptor T Cell Therapy for Patients with Relapsed/Refractory Multiple Myeloma. Transplantation and Cellular Therapy. 30(3). 298–305. 18 indexed citations
6.
Mou, Junmin, et al.. (2023). Model predictive control framework for green and smart tug escorting. Ocean Engineering. 280. 114539–114539. 3 indexed citations
7.
Dima, Danai, James A. Davis, Nausheen Ahmed, et al.. (2023). Safety and Efficacy of Teclistamab in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World Experience. Transplantation and Cellular Therapy. 30(3). 308.e1–308.e13. 40 indexed citations
8.
OʼShea, Patrick, Atulya Aman Khosla, Ahmad Ozair, et al.. (2023). Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010–2019 Retrospective Cohort Study. Cancers. 15(11). 3015–3015. 7 indexed citations
9.
Ren, Minqiao, Xuanbo Liu, Xuefei Jia, et al.. (2022). Memory of crystallization in the melt of commercial linear low density polyethylenes processed in an open twin-screw extruder. Thermochimica Acta. 720. 179423–179423. 2 indexed citations
10.
Thapa, Bicky, Xuefei Jia, Hamed Daw, et al.. (2022). Metaplastic Breast Cancer: Characteristics and Survival Outcomes. Cureus. 14(8). e28551–e28551. 14 indexed citations
11.
Shah, Chirag, Brian P. Hobbs, Frank A. Vicini, et al.. (2020). The Diminishing Impact of Margin Definitions and Width on Local Recurrence Rates following Breast-Conserving Therapy for Early-Stage Invasive Cancer: A Meta-Analysis. Annals of Surgical Oncology. 27(12). 4628–4636. 8 indexed citations
12.
Jia, Xuefei, et al.. (2019). Clinical outcomes of isolated distal deep vein thrombosis versus proximal venous thromboembolism in cancer patients: The Cleveland Clinic experience. Journal of Thrombosis and Haemostasis. 18(3). 651–659. 19 indexed citations
13.
Gervaso, Lorenzo, Alberto J. Montero, Xuefei Jia, & Alok A. Khorana. (2019). Venous thromboembolism in breast cancer patients receiving cyclin‐dependent kinase inhibitors. Journal of Thrombosis and Haemostasis. 18(1). 162–168. 63 indexed citations
14.
Sharma, Mayur, Antonio Meola, Xuefei Jia, et al.. (2018). Correlation Between the Residual Tumor Volume, Extent of Tumor Resection, and O6-Methylguanine DNA Methyltransferase Status in Patients with Glioblastoma. World Neurosurgery. 116. e147–e161. 9 indexed citations
15.
Thapa, Bicky, et al.. (2018). Efficacy of immune checkpoint inhibitors in patients with brain metastasis from NSCLC, RCC, and melanoma.. Journal of Clinical Oncology. 36(5_suppl). 214–214. 4 indexed citations
16.
Murphy, Erin S., C.M. Leyrer, Michael Parsons, et al.. (2017). Risk Factors for Malignant Transformation of Low-Grade Glioma. International Journal of Radiation Oncology*Biology*Physics. 100(4). 965–971. 71 indexed citations
17.
Saygin, Caner, Xuefei Jia, Brian T. Hill, et al.. (2017). Impact of comorbidities on outcomes of elderly patients with diffuse large B‐cell lymphoma. American Journal of Hematology. 92(10). 989–996. 37 indexed citations
18.
Sharma, Mayur, Xuefei Jia, Manmeet S. Ahluwalia, et al.. (2017). Cumulative Intracranial Tumor Volume and Number of Brain Metastasis as Predictors of Developing New Lesions After Stereotactic Radiosurgery for Brain Metastasis. World Neurosurgery. 106. 666–675. 11 indexed citations
19.
Pleyer, Christopher, William Shomali, Paul Elson, et al.. (2015). Impact of Red Blood Cell and Platelet Transfusions in Acute Myeloid Leukemia (AML) Patients Undergoing Remission Induction Chemotherapy. Blood. 126(23). 2127–2127. 1 indexed citations
20.
Bumma, Naresh, Jing Ai, Xuefei Jia, et al.. (2014). Impact of Day 28 Absolute Lymphocyte Count on Outcome of Adult Patients with Acute Myeloid Leukemia. Blood. 124(21). 5256–5256. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026